Tao Xie

机构：University of Technology Sydney, Pfizer (United States) · ORCID：0000-0002-0580-6877

发表论文 18 篇 · 总被引 198 次 · h-index 6

代表论文

• Microglia enhance post-anesthesia neuronal activity by shielding inhibitory synapses (2024 · Nature Neuroscience · 被引 77)
• A near-infrared AIE probe and its applications for specific in vitro and in vivo two-photon imaging of lipid droplets (2022 · Biomaterials · 被引 51)
• Facile synthesis of ultrabright luminogens with specific lipid droplets targeting feature for in vivo two-photon fluorescence retina imaging (2022 · Chinese Chemical Letters · 被引 19)
• Targeting Homologous Recombination Deficiency in Ovarian Cancer with PARP Inhibitors: Synthetic Lethal Strategies That Impact Overall Survival (2022 · Cancers · 被引 16)
• PARP Inhibitors Display Differential Efficacy in Models of BRCA Mutant High-Grade Serous Ovarian Cancer (2021 · International Journal of Molecular Sciences · 被引 12)
• Aberrant SWI/SNF Complex Members Are Predominant in Rare Ovarian Malignancies—Therapeutic Vulnerabilities in Treatment-Resistant Subtypes (2024 · Cancers · 被引 11)